Similar articles

• Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.

  Goel S, Pasam RT, Sharma A, Gidwani U. Goel S, et al. Cardiovasc Revasc Med. 2020 Feb;21(2):239-241. doi: 10.1016/j.carrev.2019.08.015. Epub 2019 Aug 20. Cardiovasc Revasc Med. 2020. PMID: 31718958 No abstract available.
• Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.

  Zeymer U, Annemans L, Danchin N, Pocock S, Newsome S, Van de Werf F, Medina J, Bueno H. Zeymer U, et al. Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):121-129. doi: 10.1177/2048872618769057. Epub 2018 Apr 3. Eur Heart J Acute Cardiovasc Care. 2019. PMID: 29611427
• Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.

  Alexander JH, Wojdyla D, Vora AN, Thomas L, Granger CB, Goodman SG, Aronson R, Windecker S, Mehran R, Lopes RD. Alexander JH, et al. Circulation. 2020 May 19;141(20):1618-1627. doi: 10.1161/CIRCULATIONAHA.120.046534. Epub 2020 Mar 29. Circulation. 2020. PMID: 32223444
• 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).

  Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K; ESC Scientific Document Group. Lip GYH, et al. Europace. 2019 Feb 1;21(2):192-193. doi: 10.1093/europace/euy174. Europace. 2019. PMID: 30052888 Review.
• Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention.

  Mihajlovic M, Marinkovic M, Kozieł M, Mujovic N, Lip GYH, Potpara TS. Mihajlovic M, et al. Kardiol Pol. 2020 Jun 25;78(6):512-519. doi: 10.33963/KP.15428. Epub 2020 Jun 10. Kardiol Pol. 2020. PMID: 32543800 Review.